CONSORTIUM

The ProCAncer-I project brings together 20 partners, including PCa centers of reference, world leaders in AI and innovative SMEs, with recognized expertise in their respective domains, with the objective to design, develop and sustain a cloud-based, secure European Image Infrastructure with tools and services for data handling.

Foundation for Research and Technology Hellas (FORTH) COORDINATOR

Greece | Manolis Tsiknakis (Project Coordinator) 

FORTH is the Project Coordinator of ProCAncer-I

RadboudUMC (RUN)

The Netherlands | Jurgen Fütterer

University of Pisa (UNIPI)

Italy | Emanuele Neri

Hacettepe University, School of Medicine, Department of Radiology (HACETTEPE)

Turkey | Deniz Akata

 JCC Diagnostic Imaging (VDC)

Portugal | João Carlos Costa

General Anti-Cancer and Oncological Hospital of Athens, “St. Savvas” (GAONA)

Greece | Vasileios Katsaros

Royal Marsden National Health Service Trust (ICR)

United Kingdom| Dow-Mu Koh

QS Instituto de Investigacion e Innovacion SL (QUIRON)

Spain | Rocio Diaz-Sanchez

Consiglio Nazionale delle Ricerche (CNR)

Italy | Sara Colantonio

ADVANTIS Medical Imaging Single Member PC (ADVANTIS)

Greece | Zoi Giavri

Fundacao D. Anna Sommer Champalimaud e Dr. Carloss Montez Champalimaud (CF)

Portugal | Nikolaos Papanikolaou

Fundacion Para La Investigacion Del Hospital Universitario La Fe De La Comunidad Valenciana (HULAFE)

Spain | Luis Marti Bonmati

Institut Paoli Calmettes (PCAL)

France | Jochen Walz

Fundacio Institut D’Investigacio Biomedica De Girona Doctor Josep Trueta (IDIBGI)

Spain | Joan C. Vilanova

National Cancer Institute (NCIV)

Lithuania | Jurgita Ušinskienė

Candiolo Cancer Institute, FPO – IRCCS (FPO)

Italy | Prof. Daniele Regge

Massachusetts General Hospital (The General Hospital Corp) (QTIM)

USA | Jayashree Kalpathy-Cramer

Biotronics 3D Limited (B3D)

UK | Joao Correia

University of Vienna (UNIVIE)

Austria | Nikolaus Forgó

QUIBIM, Sociedad Limitada (QUIBIM)

Spain | Angel ALBERICH-BAYARRI

Highlights

Ελπίδα από Έλληνες επιστήμονες για τον καρκίνο του προστάτη

Ελπίδα από Έλληνες επιστήμονες για τον καρκίνο του προστάτη

Ελπίδα για καλύτερη διάγνωση, θεραπεία και βελτιωμένη ποιότητα ζωής στους ασθενείς που πάσχουν από καρκίνο του προστάτη, δίνει το νέο πανευρωπαϊκό πρόγραμμα ProCAncer-I στο οποίο συμμετέχει και η Ελλάδα καθώς συντονιστής φορέας είναι το Ινστιτούτο Τεχνολογίας και Έρευνας (ΙΤΕ) στην Κρήτη.

Fighting prostate cancer with over 1.5 million MRI images

Fighting prostate cancer with over 1.5 million MRI images

Men die about five years earlier than women across the world. As initiatives to boost awareness of men’s health unfolded in November, an international project is bringing the forefront of AI research to tackle prostate cancer (PC), the second most frequent type of cancer in men and the third most lethal in Europe.

We've opened registration for 'The Wizardry of #ArtificialIntelligence 2.0: #AI and #MachineLearning in #CancerImaging

This online meeting takes place from 22-24 July 2021. Registration fees are just £65 for all 3 days. 12 CPD points awarded.
https://www.icimagingsociety.org.uk/index.cfm?task=meetings&meetingid=232

Check out @ZDFEnterprises's interview with our CEO Zoi Giavri and COO @pziog who speak about how a #research project was transformed into a growing R&D driven company Advantis Medical Imaging with #Greek origins and a global perspective! (00:43)!
https://www.zdf.de/nachrichten/heute-in-europa/griechenlands-generation-corona-100.html

Desde Quirónsalud Marbella indican que todo varón mayor de 45 años debería concertar una visita a su urólogo una vez al año. Y en caso de antecedentes familiares de cáncer de próstata y en vasectomizados esta cita debería programarse antes, a los 40 años http://ow.ly/Rp3v50EgH9F

Save the date! 28 April #aiforindustry, a virtual congress and matchmaking event about #Artificial_Intelligence,
the key to Industry 5.0, co-organized with @secpho. Sign up here: https://bit.ly/3rjeZWj

Load More...

Stay in touch!